Hadlima

List of products in the National Drug Code with proprietary name hadlima. Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
50090-6704Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-6705Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-6706Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-6707Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
78206-183Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcHuman Prescription Drug
78206-184Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcHuman Prescription Drug
78206-185Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcHuman Prescription Drug
78206-186Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcHuman Prescription Drug
78206-187Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcHuman Prescription Drug